These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26350165)

  • 1. Chemical and Enzymatic Site Specific PEGylation of hGH: The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates.
    Grigoletto A; Mero A; Zanusso I; Schiavon O; Pasut G
    Macromol Biosci; 2016 Jan; 16(1):50-6. PubMed ID: 26350165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical and enzymatic site specific PEGylation of hGH.
    da Silva Freitas D; Mero A; Pasut G
    Bioconjug Chem; 2013 Mar; 24(3):456-63. PubMed ID: 23432141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenyl amide linker improves the pharmacokinetics and pharmacodynamics of N-terminally mono-PEGylated human growth hormone.
    Wu L; Ji S; Shen L; Hu T
    Mol Pharm; 2014 Sep; 11(9):3080-9. PubMed ID: 25115329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Terminal Modification with Pseudo-Bifunctional PEG-Hexadecane Markedly Improves the Pharmacological Profile of Human Growth Hormone.
    Wu L; Ji S; Hu T
    Mol Pharm; 2015 May; 12(5):1402-11. PubMed ID: 25849255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new PEG-beta-alanine active derivative for releasable protein conjugation.
    Pasut G; Mero A; Caboi F; Scaramuzza S; Sollai L; Veronese FM
    Bioconjug Chem; 2008 Dec; 19(12):2427-31. PubMed ID: 19053302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precise and combinatorial PEGylation generates a low-immunogenic and stable form of human growth hormone.
    Wu L; Chen J; Wu Y; Zhang B; Cai X; Zhang Z; Wang Y; Si L; Xu H; Zheng Y; Zhang C; Liang C; Li J; Zhang L; Zhang Q; Zhou D
    J Control Release; 2017 Mar; 249():84-93. PubMed ID: 28131652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel high-throughput screening method for microbial transglutaminases with high specificity toward Gln141 of human growth hormone.
    Zhao X; Shaw AC; Wang J; Chang CC; Deng J; Su J
    J Biomol Screen; 2010 Feb; 15(2):206-12. PubMed ID: 20086216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and molecular modeling of PEGylated human growth hormone with agonist activity.
    Khameneh B; Jaafari MR; Hassanzadeh-Khayyat M; Varasteh A; Chamani J; Iranshahi M; Mohammadpanah H; Abnous K; Saberi MR
    Int J Biol Macromol; 2015 Sep; 80():400-9. PubMed ID: 26116386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-acting, mono-PEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats.
    Cox GN; Rosendahl MS; Chlipala EA; Smith DJ; Carlson SJ; Doherty DH
    Endocrinology; 2007 Apr; 148(4):1590-7. PubMed ID: 17234711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method to increase selectivity of transglutaminase mediated PEGylation of salmon calcitonin and human growth hormone.
    Mero A; Schiavon M; Veronese FM; Pasut G
    J Control Release; 2011 Aug; 154(1):27-34. PubMed ID: 21565230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troubleshooting PEG-hGH detection supporting pharmacokinetic evaluation in growth hormone deficient patients.
    Myler HA; McVay S; Kratzsch J
    J Pharmacol Toxicol Methods; 2010; 61(2):92-7. PubMed ID: 20044010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/pharmacodynamic (PK/PD) differentiation of native and PEGylated recombinant human growth hormone (rhGH and PEG-rhGH) in the rat model of osteoarthritis.
    Nemirovskiy O; Zheng YJ; Tung D; Korniski B; Settle S; Skepner A; Yates M; Aggarwal P; Sunyer T; Aguiar DJ
    Xenobiotica; 2010 Aug; 40(8):586-92. PubMed ID: 20509748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation of PolyPEG to interferon alpha extends serum half-life while maintaining low viscosity of the conjugate.
    Podobnik B; Helk B; Smilović V; Škrajnar Š; Fidler K; Jevševar S; Godwin A; Williams P
    Bioconjug Chem; 2015 Mar; 26(3):452-9. PubMed ID: 25629733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal mono-PEGylation of growth hormone antagonist: correlation of PEG size and pharmacodynamic behavior.
    Wu L; Ho SV; Wang W; Gao J; Zhang G; Su Z; Hu T
    Int J Pharm; 2013 Sep; 453(2):533-40. PubMed ID: 23796830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiolated glycol chitosan bearing α-cyclodextrin for sustained delivery of PEGylated human growth hormone.
    Sivasubramanian M; Kim YJ; Chae SY; Son S; Jo DG; Lee KC; Yoo CK; Park JH
    J Biomater Sci Polym Ed; 2012; 23(15):1995-2005. PubMed ID: 22040402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-Terminally PEGylated hGH-derivatives.
    Peschke B; Zundel M; Bak S; Clausen TR; Blume N; Pedersen A; Zaragoza F; Madsen K
    Bioorg Med Chem; 2007 Jul; 15(13):4382-95. PubMed ID: 17482822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific PEGylation for high-yield preparation of Lys(21)-amine PEGylated growth hormone-releasing factor (GRF) (1-29) using a GRF(1-29) derivative FMOC-protected at Tyr(1) and Lys(12).
    Youn YS; Lee KC
    Bioconjug Chem; 2007; 18(2):500-6. PubMed ID: 17243755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.
    Fontana A; Spolaore B; Mero A; Veronese FM
    Adv Drug Deliv Rev; 2008 Jan; 60(1):13-28. PubMed ID: 17916398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo residence duration of human growth hormone loaded in nanogels comprising cinnamoyl alginate, cinnamoyl Pluronic F127 and cinnamoyl poly(ethylene glycol).
    Yoon DY; Kim JC
    Int J Pharm; 2016 Jul; 509(1-2):229-236. PubMed ID: 27242314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylation of octreotide: II. Effect of N-terminal mono-PEGylation on biological activity and pharmacokinetics.
    Na DH; Lee KC; DeLuca PP
    Pharm Res; 2005 May; 22(5):743-9. PubMed ID: 15906169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.